# Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System

> **NCT01635192** · EARLY_PHASE1 · COMPLETED · sponsor: **Göteborg University** · enrollment: 24 (actual)

## Conditions studied

- the Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in Man

## Interventions

- **BIOLOGICAL:** VSL#3
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01635192
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635192, "Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01635192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*